Black Hawk Acquisition Corp
BKHANasdaqHealthcare · Biological Products, (No Diagnostic Substances) · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$915,510 | −$576,076 | −$18,853 |
| Net income | $1.3M | $1.9M | −$18,853 |
| Total assets | $23.9M | $72.1M | $263,000 |
| Total liabilities | $3.9M | $2.5M | $256,853 |
| Equity | −$3.8M | −$2.2M | $6,147 |
| EPS (diluted) | — | — | — |
| Shares out. | 8.9M | — | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −34.6%
- Return on assets
- 5.6%
- Return on capital (ROCE)
- −4.1%
- Liabilities / assets
- 16.3%
- Debt / equity
- —
- Book value / share
- $-0.43
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −30.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -2.21distress
- Accruals / assets
- 8.3%moderate
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 1 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Apr 14, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 2, 2026
- NT 10-Qmissed a reporting deadline ↗Oct 15, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- First Trust Capital Management L.P.Passive (13G)Nov 14, 2025
- Propper KerryPassive (13G)Nov 13, 2025
- Aqr Capital Management LlcPassive (13G)Nov 12, 2025
- Berkley W R CorpPassive (13G)Nov 10, 2025
- Wolverine Asset Management LlcPassive (13G)Oct 10, 2025
- Mizuho Financial Group IncPassive (13G)Aug 13, 2025
- Karpus Management, Inc.Passive (13G)Aug 7, 2025
- Td Securities (Usa) LlcPassive (13G)May 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 54 | 1.0 | -49.1% |
| Apr 30, 2026 | 106 | 1.0 | +68.3% |
| Apr 15, 2026 | 63 | 1.0 | -40.6% |
| Mar 31, 2026 | 106 | 1.0 | -48.5% |
| Mar 13, 2026 | 206 | 1.0 | +38.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · New financial obligation · Unregistered equity saleMay 8, 2026
- Delisting / listing-standard noticeApr 1, 2026
- Director / officer change · Regulation FD disclosureMar 17, 2026
- Entered a material agreement · New financial obligation · Unregistered equity saleFeb 19, 2026
- Director / officer changeFeb 3, 2026
- Other material eventSep 24, 2025
- Other material eventAug 28, 2025
- Other material eventAug 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.